World's Best Scientists 2026 revealed!
VIEW LIST
Olli Silvennoinen

Olli Silvennoinen

Tampere University
Finland

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 63 1781 1603 7 6 130 19893

Olli Silvennoinen publications per year

The chart shows the history of publications by Olli Silvennoinen between 1984 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Olli Silvennoinen published across 42 years, from 1984 to 2025, averaging 4.1 papers a year. Output peaked at 10 publications in 2012. 9 of the 171 publications appeared in the last two years.

No. of publications
2 4 6 8 10
Bar chart. Horizontal axis: year, 1984 to 2025. Vertical axis: number of publications, 0 to 10. Peak 10 publications in 2012. 1984: 1 publication 1985: 0 publications 1986: 1 publication 1987: 0 publications 1988: 1 publication 1989: 0 publications 1990: 2 publications 1991: 2 publications 1992: 1 publication 1993: 8 publications 1994: 6 publications 1995: 3 publications 1996: 4 publications 1997: 4 publications 1998: 3 publications 1999: 0 publications 2000: 7 publications 2001: 0 publications 2002: 8 publications 2003: 7 publications 2004: 4 publications 2005: 5 publications 2006: 4 publications 2007: 6 publications 2008: 3 publications 2009: 2 publications 2010: 9 publications 2011: 5 publications 2012: 10 publications 2013: 7 publications 2014: 8 publications 2015: 8 publications 2016: 3 publications 2017: 2 publications 2018: 4 publications 2019: 7 publications 2020: 2 publications 2021: 5 publications 2022: 4 publications 2023: 6 publications 2024: 5 publications 2025: 4 publications
1984 2025

171 publications in total across all disciplines

View publications per year as a table
Olli Silvennoinen: publications per year, 1984 to 2025
Year Publications
1984 1
1985 0
1986 1
1987 0
1988 1
1989 0
1990 2
1991 2
1992 1
1993 8
1994 6
1995 3
1996 4
1997 4
1998 3
1999 0
2000 7
2001 0
2002 8
2003 7
2004 4
2005 5
2006 4
2007 6
2008 3
2009 2
2010 9
2011 5
2012 10
2013 7
2014 8
2015 8
2016 3
2017 2
2018 4
2019 7
2020 2
2021 5
2022 4
2023 6
2024 5
2025 4
Total 171
Download as CSV

Olli Silvennoinen publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Olli Silvennoinen sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 127–136 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 130 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158 130
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Olli Silvennoinen D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Olli Silvennoinen sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 62–63 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 63 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105 63
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Overview

Olli Silvennoinen is affiliated with Tampere University in Finland and has contributed extensively to the field of medicine, with a particular focus on genetics, oncology, rheumatology, hematology, and molecular biology. Their research primarily addresses cytokine signaling pathways, myeloproliferative neoplasms, and rheumatoid arthritis, among other topics.

Their work includes investigations into rheumatoid arthritis therapies, acute myeloid leukemia, systemic lupus erythematosus, chronic myeloid leukemia treatments, and eosinophilic disorders and syndromes.

Frequent coauthors in Silvennoinen's research include Anniina Virtanen, T. Haikarainen, Pia Isomäki, Maaria Palmroth, and Ritva Peltomaa.

Olli Silvennoinen has published several papers, including the following:

  • Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response, 2021, Frontiers in Immunology
  • JAK inhibitor selectivity: new opportunities, better drugs?, 2024, Nature Reviews Rheumatology
  • Janus Kinases in Leukemia, 2021, Cancers
  • Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response, 2022, Clinical & Experimental Immunology
  • Differences in JAK Isoform Selectivity Among Different Types of JAK Inhibitors Evaluated for Rheumatic Diseases Through In Vitro Profiling, 2023, Arthritis & Rheumatology

Their research is frequently published in journals such as Frontiers in Immunology, Cancers, Pharmaceuticals, Science Advances, and FASEB BioAdvances.

Best Publications

  • JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

    Bruce A. Witthuhn;Frederick W. Quelle;Olli Silvennoinen;Taolin Yi

  • Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

    Lawrence S. Argetsinger;George S. Campbell;Xianjie Yang;Bruce A. Witthuhn

  • Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

    Neil Stahl;Teri G. Boulton;Thomas Farruggella;Nancy Y. Ip

  • The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction

    Mathias Müller;James Briscoe;Carl Laxton;Dmitry Guschin

  • Signaling by the cytokine receptor superfamily: JAKs and STATs

    James N. Ihle;Bruce A. Witthuhn;Frederick W. Quelle;Koh Yamamoto

  • SIGNALING THROUGH THE HEMATOPOIETIC CYTOKINE RECEPTORS

    James N. Ihle;Bruce A. Witthuhn;Frederick W. Quelle;Koh Yamamoto

  • Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells

    Bruce A. Witthuhn;Olli Silvennoinen;Osamu Miura;Osamu Miura;Koon Siew Lai

  • The Janus kinases (Jaks)

    Kunihiro Yamaoka;Pipsa Saharinen;Marko Pesu;Vance E.T. Holt

  • Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain

    Pipsa Saharinen;Kati Takaluoma;Olli Silvennoinen;Olli Silvennoinen

  • Interferon-induced nuclear signalling by Jak protein tyrosine kinases

    Olli Silvennoinen;James N. Ihle;Joseph Schlessinger;David E. Levy

  • The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.

    Pipsa Saharinen;Olli Silvennoinen;Olli Silvennoinen

  • Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130.

    Masashi Narazaki;Bruce A. Witthuhn;Kanji Yoshida;Olli Silvennoinen

  • Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.

    Anna L. Lahti;Ville J. Kujala;Hugh Chapman;Ari-Pekka Koivisto

  • Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1

    Daniela Ungureanu;Pipsa Saharinen;Ilkka Junttila;Douglas J. Hilton

  • The Pseudokinase Domain of JAK2 Is a Dual-Specificity Protein Kinase That Negatively Regulates Cytokine Signaling

    Daniela Ungureanu;Jinhua Wu;Jinhua Wu;Tuija Pekkala;Yashavanthi Niranjan

  • Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.

    Pipsa Saharinen;Mauno Vihinen;Olli Silvennoinen

  • A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.

    James M. Murphy;James M. Murphy;Qingwei Zhang;Samuel N. Young;Michael L. Reese

  • Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F

    Rajintha M Bandaranayake;Daniela Ungureanu;Yibing Shan;David E Shaw;David E Shaw

  • ARIP3 (Androgen Receptor-Interacting Protein 3) and Other PIAS (Protein Inhibitor of Activated STAT) Proteins Differ in Their Ability to Modulate Steroid Receptor-Dependent Transcriptional Activation

    Noora Kotaja;Saara Aittomäki;Olli Silvennoinen;Jorma J. Palvimo

  • Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome.

    Jens F. Sundström;Alena Vaculova;Andrei P. Smertenko;Eugene I. Savenkov

Frequent Co-Authors

Stevan R. Hubbard
Stevan R. Hubbard New York University
Mika Rämet
Mika Rämet Oulu University Hospital
James N. Ihle
James N. Ihle St. Jude Children's Research Hospital
Xi Yang
Xi Yang University of Manitoba
David E. Shaw
David E. Shaw D. E. Shaw Research
Jorma J. Palvimo
Jorma J. Palvimo University of Eastern Finland
John J. O'Shea
John J. O'Shea National Institutes of Health
James M. Murphy
James M. Murphy Walter and Eliza Hall Institute of Medical Research
Jeffrey J. Babon
Jeffrey J. Babon Walter and Eliza Hall Institute of Medical Research
Timo Otonkoski
Timo Otonkoski University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology opens doors to a variety of scientific and healthcare fields. Many students consider online degrees for flexibility and cost savings. For related interests, an online Master of Library and Information Science is a popular choice, but students should carefully weigh the cost of mlis degree us to find affordable options.

For those interested in healthcare and communications, speech-language pathology (SLP) is another rewarding path. There are asha certified slp programs available online that can lead to licensure and a meaningful career helping others. If your background is not in communication sciences, an slp bridge program online can let you transition into this field with bridge courses.

For non-nursing graduates, moving into nursing is also possible. Consider an non nursing degree to bsn online option to fast-track your entry into healthcare practice.

Best Scientists Citing Olli Silvennoinen

James M. Murphy

James M. Murphy

Walter and Eliza Hall Institute of Medical Research

Publications: 78

John J. O'Shea

John J. O'Shea

National Institutes of Health

Publications: 65

Stefan N. Constantinescu

Stefan N. Constantinescu

Ludwig Cancer Research

Publications: 63

Peter C. Heinrich

Peter C. Heinrich

University of Freiburg

Publications: 56

Warren J. Leonard

Warren J. Leonard

National Institutes of Health

Publications: 49

Fred Schaper

Fred Schaper

Otto-von-Guericke University Magdeburg

Publications: 31

Christin Carter-Su

Christin Carter-Su

University of Michigan–Ann Arbor

Publications: 29

Tadamitsu Kishimoto

Tadamitsu Kishimoto

Osaka University

Publications: 28

William Vainchenker

William Vainchenker

Institut Gustave Roussy

Publications: 27

James N. Ihle

James N. Ihle

St. Jude Children's Research Hospital

Publications: 27

Jeffrey J. Babon

Jeffrey J. Babon

Walter and Eliza Hall Institute of Medical Research

Publications: 26

Peter E. Czabotar

Peter E. Czabotar

Walter and Eliza Hall Institute of Medical Research

Publications: 25

Nicos A. Nicola

Nicos A. Nicola

Walter and Eliza Hall Institute of Medical Research

Publications: 25

Iris Behrmann

Iris Behrmann

University of Luxembourg

Publications: 24

Mika Rämet

Mika Rämet

Oulu University Hospital

Publications: 24

Klaus Elenius

Klaus Elenius

University of Turku

Publications: 23

Trending Scientists

Jin-Yoo Suh

Jin-Yoo Suh

Korea Institute of Science and Technology

Stein Andersson

Stein Andersson

University of Oslo

Karl-Klaus Conzelmann

Karl-Klaus Conzelmann

Ludwig-Maximilians-Universität München

Terry W. Moody

Terry W. Moody

National Institutes of Health

Alain Trautmann

Alain Trautmann

Institut Cochin

Henian Chen

Henian Chen

University of South Florida

Brian J. Reiser

Brian J. Reiser

Northwestern University

James L. Manley

James L. Manley

Columbia University

Bin Liang

Bin Liang

Tsinghua University

Eric Udd

Eric Udd

Philips (Finland)

Pasquale De Meo

Pasquale De Meo

University of Messina

Makram T. Suidan

Makram T. Suidan

University of Cincinnati

Richard M. Venable

Richard M. Venable

National Institutes of Health

Bruno Donnadieu

Bruno Donnadieu

University of California, Riverside

Stelios Katsanevakis

Stelios Katsanevakis

University of the Aegean

Sebastian Diehl

Sebastian Diehl

Umeå University

Related Molecular Biology Rankings & Guides

2027 Dental Assistant Salary by State

2027 Dental Assistant Salary by State
2027 How to Become a Medical Biller & Coder in Reno, NV: Education Requirements & Certification

2027 How to Become a Medical Biller & Coder in Reno, NV: Education Requirements & Certification
2027 How to Become a Clinical Director: Salary & Career Paths

2027 How to Become a Clinical Director: Salary & Career Paths
2027 Certified Nurse Aide (CNA) License Education Requirements in Virginia

2027 Certified Nurse Aide (CNA) License Education Requirements in Virginia
2027 Average Travel Nurse Salary by State: How Much Do Travel Nurses Make?

2027 Average Travel Nurse Salary by State: How Much Do Travel Nurses Make?
2027 Highest-Paying Jobs in Health Science

2027 Highest-Paying Jobs in Health Science
2027 How to Become a Child Life Specialist – Salary & Requirements

2027 How to Become a Child Life Specialist – Salary & Requirements
2027 How to Become a Medical Biller & Coder in Las Vegas, NV: Education Requirements & Certification

2027 How to Become a Medical Biller & Coder in Las Vegas, NV: Education Requirements & Certification
2027 How to Become a Medical Biller & Coder in Florida

2027 How to Become a Medical Biller & Coder in Florida
2027 How to Become a Caregiver: Certification Requirements in Maryland

2027 How to Become a Caregiver: Certification Requirements in Maryland
2027 How to Become a Holistic Nurse Practitioner

2027 How to Become a Holistic Nurse Practitioner
2027 Fastest Way to Become a Radiology Tech

2027 Fastest Way to Become a Radiology Tech
2027 How to Become a Caregiver: Certification Requirements in Florida

2027 How to Become a Caregiver: Certification Requirements in Florida
2027 Best RN to MSN Programs (No BSN Required)

2027 Best RN to MSN Programs (No BSN Required)
2027 How to Become a Licensed Pharmacist in Dallas, TX: License Requirements

2027 How to Become a Licensed Pharmacist in Dallas, TX: License Requirements
2027 How to Become a Caregiver: Certification Requirements in Oregon

2027 How to Become a Caregiver: Certification Requirements in Oregon
2027 How Much Do Ultrasound Technicians Make?

2027 How Much Do Ultrasound Technicians Make?
2027 How to Become a Licensed Pharmacist in New Jersey

2027 How to Become a Licensed Pharmacist in New Jersey
2027 How to Become a Medical Assistant in Washington Online

2027 How to Become a Medical Assistant in Washington Online
2027 How to Become a Medical Biller & Coder in Toledo, OH: Education Requirements & Certification

2027 How to Become a Medical Biller & Coder in Toledo, OH: Education Requirements & Certification
2027 Easiest Types of Doctor to Become & How to Get There

2027 Easiest Types of Doctor to Become & How to Get There

Recently Published Articles

2027 Nurse Administrator Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles

2027 Nurse Administrator Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles
2027 Different Types of Nurse Leadership Degrees and Their Salaries

2027 Different Types of Nurse Leadership Degrees and Their Salaries
2027 Are Too Many Students Choosing Social Work? Oversaturation, Competition, and Hiring Reality

2027 Are Too Many Students Choosing Social Work? Oversaturation, Competition, and Hiring Reality
2027 What Can You Do with a Dual MSN/MBA Degree?

2027 What Can You Do with a Dual MSN/MBA Degree?
2027 Most Affordable Online Master's in Instructional Design Programs

2027 Most Affordable Online Master's in Instructional Design Programs
2027 Most Popular Concentrations in Bioinformatics Degrees

2027 Most Popular Concentrations in Bioinformatics Degrees
2027 Fastest Online Creative Writing Bachelor's Degree Programs You Can Finish in 3 Years or Less

2027 Fastest Online Creative Writing Bachelor's Degree Programs You Can Finish in 3 Years or Less
2027 How to Transition from BSN to CRNA: Length, Education & Training Requirements

2027 How to Transition from BSN to CRNA: Length, Education & Training Requirements
2027 MSN Resume Tips

2027 MSN Resume Tips
2027 Artificial Intelligence Degree Programs Best for Remote Work Careers

2027 Artificial Intelligence Degree Programs Best for Remote Work Careers
2027 Work Experience Requirements for Occupational Therapy Degree Master's Programs

2027 Work Experience Requirements for Occupational Therapy Degree Master's Programs
2027 Licensing Exams Required After Completing an Environmental Science Degree Program

2027 Licensing Exams Required After Completing an Environmental Science Degree Program
2027 How to Become an English Teacher in Indiana: Requirements & Certification

2027 How to Become an English Teacher in Indiana: Requirements & Certification
2027 What Can You Do with a Biomedical Engineering Degree: Careers

2027 What Can You Do with a Biomedical Engineering Degree: Careers
2027 Best Online Architecture Degree Master's Programs for Career Changers

2027 Best Online Architecture Degree Master's Programs for Career Changers
2027 What Can You Do With an Associate Degree in Artificial Intelligence?

2027 What Can You Do With an Associate Degree in Artificial Intelligence?
2027 State-Approved Online Nursing Education Degree Master's Programs

2027 State-Approved Online Nursing Education Degree Master's Programs
2027 Online Women’s Health Nurse Practitioner Degree Programs Costs: Tuition & Fees

2027 Online Women’s Health Nurse Practitioner Degree Programs Costs: Tuition & Fees
2027 Best Accredited Online Mechanical Engineering Bachelor's Degree Programs

2027 Best Accredited Online Mechanical Engineering Bachelor's Degree Programs
2027 Highest Level of Gerontology Degree You Can Achieve: Academic Progression Explained

2027 Highest Level of Gerontology Degree You Can Achieve: Academic Progression Explained
2027 Can You Study Biomedical Sciences Master's Programs Part-Time? Options & Duration

2027 Can You Study Biomedical Sciences Master's Programs Part-Time? Options & Duration